Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Naffakh

Showing results (11-20 of 25) with videos related to

Pageof 3
Sort By:
Nouvelle Revue Francaise D'Hematologie|January 1, 1994
Gene therapy for lysosomal disordersN Naffakh, D Bohl, A Salvetti, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1991
Gene transfer to somatic tissues using retroviral vectorsP Moullier, V Marechal, N Ferry, et al.
Virology|October 17, 2001
Hemagglutinin residues of recent human A(H3N2) influenza viruses that contribute to the inability to agglutinate chicken erythrocytesR Medeiros, N Escriou, N Naffakh, et al.
Restorative Neurology and Neuroscience|May 10, 2011
Delivery of therapeutic proteins from genetically-modified cellsN Naffakh, P Moullier, A Salvetti, et al.
The Journal of General Virology|April 18, 2000
Genetic analysis of the compatibility between polymerase proteins from human and avian strains of influenza A virusesN Naffakh, P Massin, N Escriou, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 17, 2011
Highly heterogeneous temperature sensitivity of 2009 pandemic influenza A(H1N1) viral isolates, northern FranceI Pelletier, D Rousset, V Enouf, et al.
Human Gene Therapy|January 1, 1996
Long-term secretion of therapeutic proteins from genetically modified skeletal musclesN Naffakh, C Pinset, D Montarras, et al.
Blood|May 15, 1993
Macrophage colony-stimulating factor: serum levels and cDNA structure in malignant osteopetrosisN Naffakh, S Le Gall, O Danos, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2006
Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivirM A Rameix-Welti, F Agou, P Buchy, et al.
Journal of Virology|November 6, 2009
A genetically engineered waterfowl influenza virus with a deletion in the stalk of the neuraminidase has increased virulence for chickensS Munier, T Larcher, F Cormier-Aline, et al.
Pageof 3

Showing results (11-20 of 25) with videos related to

Sort By:
Pageof 3
Nouvelle Revue Francaise D'Hematologie|January 1, 1994
Gene therapy for lysosomal disordersN Naffakh, D Bohl, A Salvetti, et al.
Nouvelle Revue Francaise D'Hematologie|January 1, 1991
Gene transfer to somatic tissues using retroviral vectorsP Moullier, V Marechal, N Ferry, et al.
Virology|October 17, 2001
Hemagglutinin residues of recent human A(H3N2) influenza viruses that contribute to the inability to agglutinate chicken erythrocytesR Medeiros, N Escriou, N Naffakh, et al.
Restorative Neurology and Neuroscience|May 10, 2011
Delivery of therapeutic proteins from genetically-modified cellsN Naffakh, P Moullier, A Salvetti, et al.
The Journal of General Virology|April 18, 2000
Genetic analysis of the compatibility between polymerase proteins from human and avian strains of influenza A virusesN Naffakh, P Massin, N Escriou, et al.
Euro Surveillance : Bulletin Europeen Sur Les Maladies Transmissibles = European Communicable Disease Bulletin|November 17, 2011
Highly heterogeneous temperature sensitivity of 2009 pandemic influenza A(H1N1) viral isolates, northern FranceI Pelletier, D Rousset, V Enouf, et al.
Human Gene Therapy|January 1, 1996
Long-term secretion of therapeutic proteins from genetically modified skeletal musclesN Naffakh, C Pinset, D Montarras, et al.
Blood|May 15, 1993
Macrophage colony-stimulating factor: serum levels and cDNA structure in malignant osteopetrosisN Naffakh, S Le Gall, O Danos, et al.
Antimicrobial Agents and Chemotherapy|August 31, 2006
Natural variation can significantly alter the sensitivity of influenza A (H5N1) viruses to oseltamivirM A Rameix-Welti, F Agou, P Buchy, et al.
Journal of Virology|November 6, 2009
A genetically engineered waterfowl influenza virus with a deletion in the stalk of the neuraminidase has increased virulence for chickensS Munier, T Larcher, F Cormier-Aline, et al.
Pageof 3